BEN vs PLX · P/E 36, rev $8.77B vs P/E 31, rev $53.4M
Franklin Resources Inc (BEN) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the BEN and PLX stock pages for the full models.
Not investment advice.